234 related articles for article (PubMed ID: 26376419)
1. [Patients with chronic obstructive pulmonary disease and heart disease can benefit from beta-blocker treatment].
Rasmussen DB; Lange P; Jensen MT
Ugeskr Laeger; 2015 Sep; 177(38):V02150184. PubMed ID: 26376419
[TBL] [Abstract][Full Text] [Related]
2. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
3. β-Blockers, heart disease and COPD: current controversies and uncertainties.
Baker JG; Wilcox RG
Thorax; 2017 Mar; 72(3):271-276. PubMed ID: 27927840
[TBL] [Abstract][Full Text] [Related]
4. Association of beta-blocker use and selectivity with outcomes in patients with heart failure and chronic obstructive pulmonary disease (from OPTIMIZE-HF).
Mentz RJ; Wojdyla D; Fiuzat M; Chiswell K; Fonarow GC; O'Connor CM
Am J Cardiol; 2013 Feb; 111(4):582-7. PubMed ID: 23200803
[TBL] [Abstract][Full Text] [Related]
5. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter SS; Ormiston T; Salpeter E; Poole P; Cates C
Cochrane Database Syst Rev; 2002; (2):CD003566. PubMed ID: 12076486
[TBL] [Abstract][Full Text] [Related]
6. [Beta-blockers and obstructive pulmonary diseases: such an odd couple?].
Grosgurin O; Bria A; Gaspoz JM
Rev Med Suisse; 2006 Jan; 2(50):285-8. PubMed ID: 16503045
[TBL] [Abstract][Full Text] [Related]
7. Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.
Salpeter SR; Ormiston TM; Salpeter EE; Poole PJ; Cates CJ
Respir Med; 2003 Oct; 97(10):1094-101. PubMed ID: 14561016
[TBL] [Abstract][Full Text] [Related]
8. [Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].
Glaab T; Weiss T
Internist (Berl); 2004 Feb; 45(2):221-7. PubMed ID: 14991165
[TBL] [Abstract][Full Text] [Related]
9. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
10. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
11. Use of cardioselective β-blockers and overall death and cardiovascular outcomes in patients with COPD: a population-based cohort study.
Dong YH; Chang CH; Wu LC; Lai MS
Eur J Clin Pharmacol; 2016 Oct; 72(10):1265-1273. PubMed ID: 27444174
[TBL] [Abstract][Full Text] [Related]
12. Beta Adrenergic Blocker Use in Patients With Chronic Obstructive Pulmonary Disease and Concurrent Chronic Heart Failure With a Low Ejection Fraction.
Mtisi TF; Frishman WH
Cardiol Rev; 2020; 28(1):20-25. PubMed ID: 31804289
[TBL] [Abstract][Full Text] [Related]
13. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
[TBL] [Abstract][Full Text] [Related]
14. Cardioselective beta-blockers for chronic obstructive pulmonary disease.
Salpeter S; Ormiston T; Salpeter E
Cochrane Database Syst Rev; 2005 Oct; 2005(4):CD003566. PubMed ID: 16235327
[TBL] [Abstract][Full Text] [Related]
15. The role of beta-blockers in the management of chronic obstructive pulmonary disease.
Leitao Filho FS; Alotaibi NM; Yamasaki K; Ngan DA; Sin DD
Expert Rev Respir Med; 2018 Feb; 12(2):125-135. PubMed ID: 29258360
[TBL] [Abstract][Full Text] [Related]
16. Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.
Du Q; Sun Y; Ding N; Lu L; Chen Y
PLoS One; 2014; 9(11):e113048. PubMed ID: 25427000
[TBL] [Abstract][Full Text] [Related]
17. Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study.
Short PM; Lipworth SI; Elder DH; Schembri S; Lipworth BJ
BMJ; 2011 May; 342():d2549. PubMed ID: 21558357
[TBL] [Abstract][Full Text] [Related]
18. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
[TBL] [Abstract][Full Text] [Related]
19. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
[TBL] [Abstract][Full Text] [Related]
20. Use of beta-blockers in patients with COPD.
Andrus MR; Holloway KP; Clark DB
Ann Pharmacother; 2004 Jan; 38(1):142-5. PubMed ID: 14742808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
